Feb 29 (Reuters) - Valeant Pharmaceuticals International Inc (N:VRX) VRX.TO :
* Valeant pharmaceuticals international- co does not expect it will be in
position to file annual report on form 10-k within 15-day extension period
* To date,co not determined if any restatements will be required,whether any
control deficiencies constitute material weaknesses
* Source text - http://1.usa.gov/1Tj2tmX
* Further company coverage VRX.TO